536 (Potassium citrate extended-release 5 mEq)
Pill imprint 536 has been identified as Potassium citrate extended-release 5 mEq.
Potassium citrate is used in the treatment of nephrolithiasis; renal tubular acidosis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 5 mEq is not a controlled substance under the Controlled Substance Act (CSA).
More about potassium citrate
- Other brands: Urocit-K
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.